References
- Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008;84:77–82
- Menke MN, Framme C, Nelle M, et al. Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease. BMC Ophthalmol 2015;15:20–5
- Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007;10:133–40
- Hellstrom A, Perruzzi C, Ju M, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001;98:5804–8
- Smith LE. Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 2002;91:26–8
- Arambilo O, Dib G, Iturralde J, et al. Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity. Clin Ophthalmol 2015;9:2027–32
- Yi Z, Su Y, Zhou Y, et al. Effects of intravitreal ranibizumab in the treatment of retinopathy of prematurity in Chinese infants. Curr Eye Res 2015;18:1–6
- Salman AG, Said AM. Structural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retinopathy of prematurity. Ophthalmic Res 2015;53:15–20
- Levinger E, Trivizki O, Shachar Y, et al. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2014;252:811–16
- Chaberny IE, Schnitzler P, Geiss HK, Wendt C. An outbreak of epidemic keratoconjunctivtis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol 2003;24:514–19
- Calkavur S, Olukman O, Ozturk AT, et al. Epidemic adenoviral keratoconjunctivitis possibly related to ophthalmological procedures in a neonatal intensive care unit: lessons from an outbreak. Ophthal Epidemiol 2012;19:371–9
- Ersoy Y, Otlu B, Türkçüoğlu P, et al. Outbreak of adenovirus serotype 8 conjunctivitis in preterm infants in a neonatal intensive care unit. J Hosp Infect 2012;80:144–9
- Koçluk Y, Sukgen EA. Different clinical presentations of the same epidemic keratoconjunctivitis outbreak in premature babies and their parents. Ocul Immunol Inflamm 2016;6:1–6
- Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684–94
- Meyer-Rusenberg B, Loderstadt U, Richard G, et al. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int 2011;108:475–9
- Trinavarat A, Atchaneeyasakul L. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study. J Ocul Pharmacol Ther 2012;28:53–8
- Tunay ZÖ, Ozdemir O, Petricli IS. Povidone iodine in the treatment of adenoviral conjunctivitis in infants. Cutan Ocul Toxicol 2015;34:12–15
- Chintakuntlawar AV, Chodosh J. Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis. Ocul Immunol Inflamm 2010;18:341–5
- Gunay M, Celik G, Con R. Treatment for retinopathy of prematurity in an infant with adenoviral conjunctivitis. Case Rep Pediatr 2015;192:71–4